Cartesian Therapeutics shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.9M | 380k | 10.22 |
| 2025-06-30 | $7.1M | 686k | 10.39 |
| 2025-03-31 | $10M | 791k | 13.18 |
| 2024-12-31 | $13M | 721k | 17.91 |
| 2024-09-30 | $10M | 629k | 16.12 |
| 2024-06-30 | $7.0M | 260k | 27.01 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management